PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2067401
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2067401
AI-Driven Rehabilitation Robotics market size was valued at US$ 3,610.82 Million in 2025, expanding at a CAGR of 25.10% from 2026 to 2033.
AI rehabilitation robotics is robotic technologies applying the artificial intelligence principles to tailor rehabilitation treatments. Such devices will monitor the patient's performance and track his/her recovery by altering rehabilitation tasks accordingly in real time. The AI-Driven Rehabilitation Robotics market is expected to expand greatly in the coming years, driven by the escalating utilization of AI-powered robotic devices to facilitate individualized recovery and rehabilitation of patients within diverse healthcare applications. In 2025, Fourier Rehab (Fourier Intelligence) advanced the utilization of AI-powered robotic rehabilitation devices by showcasing its embodied AI vision and intelligent rehabilitation technologies at RehabWeek 2025, highlighting AI-integrated robotic systems designed to enhance neurorehabilitation outcomes. Hence, increasing use of AI rehab systems will help the market expand.
AI-Driven Rehabilitation Robotics Market- Market Dynamics
Expansion of rehabilitation facilities to propel market demand
This expansion of rehabilitation facilities is an indicator of a significant shift by a prominent healthcare system to build an all-new, state-of-the-art inpatient rehabilitation hospital. This decision reflects demand and a push toward providing a higher level of rehabilitation for patients with serious injuries, neurological impairments, and post-acute needs, as well as allowing for the provision of contemporary therapeutic settings, state-of-the-art clinical technologies, and an innovative approach to patient recovery plans in an effort to positively impact recovery outcomes.
AI-Driven Rehabilitation Robotics market growth is fueled by the continuous expansion of rehabilitation facilities due to the increasing investments made in rehabilitation centers and healthcare infrastructure. For instance, according to the World Health Organization's Rehabilitation 2030 initiative, 1 in 3 people worldwide could benefit from rehabilitation services, yet in some low- and middle-income countries, over 50% of individuals requiring rehabilitation lack access to the necessary care. To expand rehabilitation facilities and improve service availability, WHO has supported approximately 78 countries in strengthening rehabilitation systems and identified 10 strategic action areas focused on service delivery expansion, workforce development, financing, and integration of rehabilitation into all levels of healthcare. Therefore, better rehab access and facilities will increase demand for AI rehab robots.
The Global AI-Driven Rehabilitation Robotics market is segmented on the basis of Product Type, Application, Technology, End User, and Region.
Among the given product types, lower limb/gait rehabilitation robots account for a prominent share, as these are some of the common types that are widely used for recovering walking ability and mobility and also for assisting patients with neurological and musculoskeletal impairments during therapy. In 2026, peer-reviewed clinical evidence from the National Library of Medicine highlights that nearly 70% of stroke survivors experience long-term gait impairments, significantly affecting mobility and independence. While about 65%-85% regain basic walking ability within six months, many continue to face balance, speed, and coordination deficits. Clinical studies involving over 3,000 patients across 40+ trials show that lower limb rehabilitation robots improve gait recovery outcomes when used alongside conventional therapy. So leg rehab robots greatly improve walking recovery when combined with extra therapy.
Under given technology segments, sensor-based motion tracking accounts for a prominent share due to heavy use for tracking human movement in real time, for evaluating the rehabilitation course, and for reliable biomechanical feedback that is used in AI-based rehabilitation robots. In 2025, Wandercraft SAS advanced its AI-driven rehabilitation robotics systems by strengthening sensor-based motion tracking within its self-balancing exoskeleton platform, improving gait analysis accuracy, and supporting enhanced patient mobility and neurorehabilitation outcomes across clinical applications. Hence, sensor-based motion tracking boosts rehab accuracy and patient mobility in robots.
AI-Driven Rehabilitation Robotics Market- Geographical Insights
From a geographical point of view, North America stands out in the AI-Driven Rehabilitation Robotics market. This leadership will be fueled by its extensive healthcare system, strong research infrastructure, and swift adoption of intelligent rehabilitation. For instance, in 2026, according to the Commonwealth Fund's "U.S. Health Care from a Global Perspective" issue brief, the United States continues to operate one of the most extensive and high-cost healthcare systems globally, with national health expenditure exceeding roughly 17-18% of GDP and per capita spending estimated at over $12,000-$13,000 USD annually, significantly higher than peer high-income countries. So, high healthcare spending and facilities keep North America the market leader.
Canada AI-Driven Rehabilitation Robotics Market- Country Insights
The AI-Driven Rehabilitation Robotics market in Canada is driven by its robust research capabilities, growing healthcare innovation, and increased integration into various therapeutic rehabilitation processes. In 2025, Bionik Laboratories Corp. advanced its AI-driven therapeutic rehabilitation robotics portfolio through its InMotion robotic therapy systems, which are widely used in clinical settings to support post-stroke and neurological recovery by assisting upper and lower limb motor relearning, improving patient mobility outcomes, and enhancing therapist-guided rehabilitation efficiency. So, AI rehab robots in Canada boost brain recovery with advanced care and new therapies.
The market is dominated by prominent firms like Tyromotion GmbH, Bionik Laboratories Corp., Myomo, Inc., Wandercraft SAS, and Motorika Medical Ltd. They are at the forefront of AI- Driven rehabilitation systems designed for neurorehabilitation and physical rehabilitation therapy. These firms enhance their positions in the market through the development of AI-powered motion support devices, adaptive therapy systems, and smart sensor integration to enhance rehabilitation outcomes. In October 2025, Tyromotion launched its Lexo robotic gait trainer in select European and Asian markets, expanding its clinical rehabilitation robotics portfolio with advanced gait and mobility therapy systems. Strengthens gait rehabilitation offerings and expands hospital adoption across Europe and Asia-Pacific clinical networks. Therefore, Tyromotion's therapy robots gain wider use in global healthcare.
In March 2026, Myomo reported continued commercial expansion of its MyoPro wearable robotics platform, driven by increased patient authorisations and sustained adoption in neurological rehabilitation markets. Improves recurring revenue visibility and strengthens reimbursement-backed adoption in the neuro-rehabilitation orthotics segment.
In October 2025, Bionik Laboratories entered a strategic distribution agreement with a major Western European medical logistics network, aimed at scaling deployment of its In Motion rehabilitation robotic systems across outpatient clinics and hospitals. Expands the European commercialization footprint and improves accessibility of AI-driven upper-limb rehabilitation systems.